Glaxosmithkline | GSK - 대출 자본

주가
51.41
매일 변경
-7.71 -13.04%
매월
-13.25%
매년
29.01%
Q2 예상
53.52




대출 자본 변화 날짜
AbbVie USD 58.94B 4.03B 2025-12
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 25.96B 177M 2026-03
Aurora Cannabis CAD 33.2M 1.79M 2025-12
Bausch Health Companies USD 20.62B 152M 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Canopy Growth CAD 224.99M 1.34M 2025-12
Drreddys Laboratories INR 129.19M 1.84M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
GlaxoSmithKline GBP 14.71B 186M 2025-12
Glaxosmithkline GBP 19.82B 203.13M 2025-12
J&J USD 37.53B 1.91B 2026-03
Merck USD 39.97B 6B 2025-09
Novartis USD 29.59B 5.35B 2025-12
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Pfizer USD 57.41B 93M 2025-09
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Takeda JPY 4.27T 81.29B 2025-12
Teva Pharmaceutical Industries USD 14.02B 971M 2026-03
Zoetis USD 9.04B 1.97B 2025-12